About the event

Held over a weekend, the event is structured around a series of exhibitions, workshops, and panel discussions. The exhibitions showcase a curated selection of photographs that tell compelling stories from various corners of the globe, each image accompanied by detailed narratives that provide context and deeper insight into the historical significance of the scenes depicted. These photographs are drawn from the archives of renowned photographers, as well as emerging talents, ensuring a blend of both classical and contemporary perspectives.

Cliff Palace, Colorado
American Healthcare REIT Inc (AHR)’s Day in Review: Closing at 48.79, Down by -0.02 – DwinneX

American Healthcare REIT Inc (AHR)’s Day in Review: Closing at 48.79, Down by -0.02

Ulysses Smith

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

After finishing at $48.8 in the prior trading day, American Healthcare REIT Inc (NYSE: AHR) closed at $48.79, down -0.02%. In other words, the price has decreased by -$0.02 from its previous closing price. On the day, 1.91 million shares were traded. AHR stock price reached its highest trading level at $49.14 during the session, while it also had its lowest trading level at $48.2.

Ratios:

Our goal is to gain a better understanding of AHR by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 49.63 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 48.46. For the most recent quarter (mrq), Quick Ratio is recorded 1.38 and its Current Ratio is at 1.38. In the meantime, Its Debt-to-Equity ratio is 0.63 whereas as Long-Term Debt/Eq ratio is at 0.63.

Upgrades & Downgrades

In the most recent recommendation for this company, UBS on September 19, 2025, initiated with a Buy rating and assigned the stock a target price of $51.

On July 18, 2025, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $41. On June 30, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $42.Scotiabank initiated its Sector Outperform rating on June 30, 2025, with a $42 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 11 ’25 when Foster Mark E. sold 1,500 shares for $49.35 per share. The transaction valued at 74,030 led to the insider holds 57,600 shares of the business.

Mark Foster bought 1,500 shares of AHR for $74,030 on Nov 11 ’25. On Nov 10 ’25, another insider, Hanson Jeffrey T, who serves as the Director of the company, sold 20,010 shares for $49.68 each. As a result, the insider received 994,105 and left with 21,798 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AHR now has a Market Capitalization of 9087848448 and an Enterprise Value of 10223358976. As of this moment, American’s Price-to-Earnings (P/E) ratio for their current fiscal year is 346.52, and their Forward P/E ratio for the next fiscal year is 68.04. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.16 while its Price-to-Book (P/B) ratio in mrq is 3.12. Its current Enterprise Value per Revenue stands at 4.66 whereas that against EBITDA is 27.251.

Stock Price History:

The Beta on a monthly basis for AHR is 0.90, which has changed by 0.65032125 over the last 52 weeks, in comparison to a change of 0.1177547 over the same period for the S&P500. Over the past 52 weeks, AHR has reached a high of $50.80, while it has fallen to a 52-week low of $26.40. The 50-Day Moving Average of the stock is 9.84%, while the 200-Day Moving Average is calculated to be 31.44%.

Shares Statistics:

The stock has traded on average 1.66M shares per day over the past 3-months and 2623440 shares per day over the last 10 days, according to various share statistics. A total of 176.91M shares are outstanding, with a floating share count of 175.36M. Insiders hold about 0.88% of the company’s shares, while institutions hold 88.35% stake in the company. Shares short for AHR as of 1763078400 were 3140482 with a Short Ratio of 2.40, compared to 1760486400 on 7222033. Therefore, it implies a Short% of Shares Outstanding of 3140482 and a Short% of Float of 1.78.

Earnings Estimates

. The current rating of American Healthcare REIT Inc (AHR) reflects the combined expertise of 3.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $0.14, with high estimates of $0.15 and low estimates of $0.14.

Analysts are recommending an EPS of between $0.52 and $0.5 for the fiscal current year, implying an average EPS of $0.51. EPS for the following year is $0.71, with 3.0 analysts recommending between $0.79 and $0.58.

Revenue Estimates

6 analysts predict $615.39M in revenue for . The current quarter. It ranges from a high estimate of $659.3M to a low estimate of $579.37M. As of . The current estimate, American Healthcare REIT Inc’s year-ago sales were $542.74MFor the next quarter, 6 analysts are estimating revenue of $627.87M. There is a high estimate of $713M for the next quarter, whereas the lowest estimate is $587.1M.

A total of 6 analysts have provided revenue estimates for AHR’s current fiscal year. The highest revenue estimate was $2.32B, while the lowest revenue estimate was $2.23B, resulting in an average revenue estimate of $2.27B. In the same quarter a year ago, actual revenue was $2.07BBased on 6 analysts’ estimates, the company’s revenue will be $2.53B in the next fiscal year. The high estimate is $2.76B and the low estimate is $2.4B.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.